Abstract
Medication-Related Osteonecrosis of the Jaw [MRONJ] is a rare but serious side effect caused by medications such as bisphosphonate and denosumab, which are used as antiresorptive medications in malignancies related to bone metastases and bone metabolism diseases. Since the major predisposing factor of this side effect may be tooth extraction, our aim in this review is to show that preventing the emergence of pathology in dental hard tissues and treating it when it occurs with a preventive and therapeutic strategy, providing adequate oral hygiene, and motivating the patient for its continuity could reduce the risk of the occurrence of MRONJ by reducing the need for oral surgery in terms of restorative dental treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
